Alphabet's AI drug discovery spinout Isomorphic Labs closed a $2.1 billion Series B led by Thrive Capital in May 2026, one of the largest financings ever for an AI-first biotech, as it races toward its first human clinical trials by late 2026.
Google and microbiome company AMILI are launching AMILI Optimise, a nutrition app that replaces calorie counting with personalized recommendations based on gut microbiome data and measured blood glucose response, reflecting a broader industry shift toward biology-driven diet apps.
Woebot Health shut down its consumer AI therapy chatbot after years pursuing FDA marketing authorization it never received, with its founder blaming a regulatory process too slow for fast-moving AI — a cautionary tale now shadowing the whole AI mental health industry.
Wysa's AI-driven CBT chatbot has received FDA Breakthrough Device Designation for chronic pain, depression, and anxiety after an independent trial found it outperformed standard orthopedic care and matched in-person counseling.
A JAMA Network Open study of over 1,400 clinicians found ambient AI scribes cut physician burnout at Mass General Brigham from 52.6% to 30.7% within 84 days, with similar well-being gains reported at Emory Healthcare and time savings confirmed in Cleveland Clinic's larger rollout.
Chai Discovery raised a $400 million Series C at a $3.8 billion valuation to scale its generative AI models for designing antibodies and proteins, building on paid discovery partnerships with Eli Lilly, Pfizer and Novartis.
A phishing attack on healthcare AI vendor Xsolis exposed sensitive data on 1.4 million patients tied to clients including Humana and Mayo Clinic Health System, with at least eight health systems confirming their patients were affected.
AI companion robot Abi, piloted in an Australian senior care home in 2025, is now coming to US facilities amid a crowded field of rivals and a $173,000 institutional robot called Moya — raising both promising acceptance rates and sharp ethical questions about cost, data, and human connection.
Germany's nationwide PRAIM program found AI-supported mammography screening lifted breast cancer detection to 6.7 per 1,000 women screened, a statistically superior 17.6% jump over standard reading, in one of the largest real-world AI screening deployments to date.
An Imperial College London study of nearly 116,000 UK mammograms found a Google AI model outperformed a radiologist's first read on sensitivity and lifted cancer detection rates from 7.54 to 9.33 per 1,000 women screened.